Since it was previously shown that activated CD8+ T cells induced gene expression of cancer cells in ICB-treated tumors24, we speculated that the increase in PRMT3 expression could be caused by the anti-PD1/PD-L1 treatment. The gene discussed is PRMT3; the disease is cancer.